Keith S Manchester, Director at Roivant Sciences, sold ROIV on Jun 26, 2026
Data as of Oct 16
- Traded
- Jun 26, 2026
- Disclosed
- Jun 30, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ROIV since disclosure
−5.3%
after the sale
Similar stocks (XLV) since disclosure
+11.4%
XLV — its sector index fund
Change in closing price from Jun 30, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLKeith S Manchester DirectorROIV Roivant Sciences Ltd.$437Kdisclosed Jun 30 · filed the same day
- ▼ SELLKeith S Manchester DirectorROIV Roivant Sciences Ltd.$7.1Mdisclosed Jun 30 · filed the same day
- ▼ SELLKeith S Manchester DirectorROIV Roivant Sciences Ltd.$6.9Mdisclosed Jun 30 · filed 1 day after the trade
- ▼ SELLKeith S Manchester DirectorROIV Roivant Sciences Ltd.$20.8Mdisclosed Jun 30 · filed 1 day after the trade
- ▼ SELLKeith S Manchester DirectorROIV Roivant Sciences Ltd.$11.1Mdisclosed Jun 30 · filed 4 days after the trade